Entasis Therapeutics, Inc.
UnclaimedPharmaceutical Preparation ManufacturingWaltham, MA
Founded
2015
Primary NAICS
325412
CAGE code
7JD21
Federal awards
—
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Research and Development in Biotechnology (except Nanobiotechnology)Drugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | -$245,721 | 1 |
| 2025 | Department of Health and Human Services | -$13,919 | 1 |
| 2023 | Department of Health and Human Services | $0 | 1 |
| 2022 | Department of Health and Human Services | $0 | 3 |